IMAX Corporation

Fundamentals5.0
Price Action3.0
News Sentiment5.0
AI Rating
6.0

Key Drivers

  • Strong margins
  • Weak quarter
  • High valuation

AI
AI Summary

6.0

IMAX is shifting from a cyclical box-office recovery story to a premium-experience platform with real upside from a strong 2026 slate, live events, and international expansion, but at ~56x earnings it now needs consistently strong cash conversion and execution to justify the valuation after the latest margin and share-price weakness.

GrowthOpportunity
Valuation
ExecutionRisk‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Strong margins
  • Weak quarter
  • High valuation

IMAX is a profitable, cash-generative business with solid balance-sheet coverage, but recent quarter softness, uneven cash conversion, and a rich valuation temper the outlook.

Profitability
RichValuation

Price Behavior

3.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Lower highs
  • Range support
  • Weak rebounds

IMAX remains in a short-term downtrend, with sellers controlling rebounds and $33.5-$33.8 acting as the key support to watch for stabilization. ക

downtrend
support
Support Level: $33.5-$33.8
Resistance Level: $35.5-$36.5

Sharp decline from $38.02 to $33.59 over the last month, with failed rebounds above $35.5-$36.5

Sentiment & News

5.0

Key News Insights:

  • Earnings Beat
  • Global Expansion
  • Insider Selling

IMAX delivered a mixed Q1 2026—earnings beat estimates and expansion/newsflow were constructive, but revenue fell year over year, margins faced pressure, China remained a headwind, and CEO insider selling drew attention.

Growth

The news is modestly positive for long-term growth thanks to network expansion and improving box office trends, but near-term sentiment may stay cautious due to margin pressure and insider sales